USPTO serial 90372396
3DMED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 21, 2023
- Examiner
- STADELI, MARTA ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with 3DMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
3D Biomedicine Science & Technology Co., Limited
Shanghai, CN
Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
3D Biomedicine Science & Technology Co., Limited
Shanghai, CN
Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
3D Biomedicine Science & Technology Co., Limited
Shanghai, CN
Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William S. Fultz
William S. Fultz WOMBLE BOND DICKINSON (US) LLP555 FAYETTEVILLE STREET, SUITE 1100RALEIGH, NC 27601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; Diagnostic preparations for scientific or research use, Diagnostic preparations for clinical or medical laboratory use | ACTIVE | Apr 21, 2020 |
| 005 | Reagents for medical use; Diagnostic preparations for medical purposes | ACTIVE | Apr 21, 2020 |
| 009 | Data processing apparatus; Recorded computer programs for biological data mining; Downloadable computer programs for developing bioinformatics database for others; Downloadable computer programs for analyzing genome information; Computer memory devices; DNA chips; Laboratory centrifuges; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Scientific apparatus and instruments for the extraction of nucleic acids for clinical research purposes | ACTIVE | Apr 21, 2020 |
| 010 | Apparatus for DNA and RNA testing for medical purposes; Medical diagnostic apparatus for testing DNA and RNA samples; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Surgical instruments and apparatus; Medical instruments for use in performing biopsies; Medical instruments for use in detecting tumors and infectious diseases; Medical instruments for use in gene testing and diagnosis in the fields of cancer, cancer companion diagnostics, screening and diagnosis of infectious diseases, and diagnosis of mental and cardiovascular diseases; Medical apparatus and instruments for the extraction of nucleic acids for clinical molecular diagnosis of infectious diseases, cancer, neurological diseases, mental diseases and cardiovascular diseases | ACTIVE | Apr 21, 2020 |
| 042 | Genetic testing for scientific research purposes; Scientific research in the field of genetics, genetic testing, and genetic diagnostics; Providing scientific research information in the field of genetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific research for medical purposes in the area of cancerous diseases; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto | ACTIVE | Aug 3, 2022 |
| 044 | Performing diagnosis of diseases; Genetic testing for medical, diagnostic, or treatment purposes | ACTIVE | Aug 3, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
- Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
- Other trademarks owned by 3D Biomedicine Science & Technology Co., Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named 3DMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 17, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 15, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 23, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 23, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 15, 2023 | IUAF | USE AMENDMENT FILED | — |
| Aug 15, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 13, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 13, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 13, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 11, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 9, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 9, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 9, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 15, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 21, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 21, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 1, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2020 | NWAP | NEW APPLICATION ENTERED | — |